arginyl-glycyl-aspartic acid has been researched along with Osteoporosis in 16 studies
*Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duggan, ME; Duong, LT; Hartman, GD; Hoffman, WF; Huff, JR; Ihle, NC; Leu, CT; Meissner, RS; Nagy, RM; Naylor-Olsen, A; Perkins, JJ; Rodan, GA; Rodan, SB; Wesolowski, GA; Whitman, DB | 1 |
| Chuang, WJ; Fu, WM; Lin, TH; Lin, YM; Liou, HC; Tu, HJ; Yang, RS | 1 |
| Liu, J; Peng, S; Zhang, X; Zhao, M | 1 |
| Li, C; Liu, J; Peng, L; Peng, S; Zhang, X; Zhao, M | 1 |
| Gamsjaeger, S; Klaushofer, K; Paschalis, EP; Rumpler, M; Spitzer, S; Thaler, R; Varga, F; Zwerina, J | 1 |
| Suzuki, K | 1 |
| Chen, KM; Dai, CL; Ding, XY; Qiu, MC; Zhang, ML; Zhang, X | 1 |
| Chen, W; Diao, W; Ji, J; Liu, J; Tang, J | 1 |
| Duggan, ME; Duong, LT; Fernandez-Metzler, C; Hartman, GD; Leu, CT; Meissner, RS; Prueksaritanont, T; Rodan, GA; Rodan, SB; Zartman, AE | 1 |
| Chang, HW; Peng, S; Wang, C; Xiong, Y; Zhao, M | 1 |
| Dresner-Pollak, R; Rosenblatt, M | 1 |
| Bianco, P; Fedarko, NS; Friedenstein, A; Grzesik, W; Hefferan, TE; Mintz, KP; Robey, PG; Van der Pluijm, G; Vetter, UK; Young, MF | 1 |
| Oursler, MJ; Spelsberg, TC | 1 |
| Chorev, M; Dresner-Pollak, R; Eshel, Y; Rosenblatt, M | 1 |
| Engleman, VW; Griggs, DW; Horton, MA; Nickols, GA; Ross, FP; Ruminski, PG; Settle, SL; Teitelbaum, SL | 1 |
| Askew, BC; Brashear, KM; Breslin, MJ; Coleman, PJ; Duggan, ME; Fernandez-Metzler, C; Hartman, GD; Hoffman, WF; Hunt, CA; Hutchinson, JH; Leu, CT; Libby, LA; Lynch, JJ; Lynch, R; Ma, B; McVean, CA; Merkle, KM; Prueksaritanont, T; Rodan, GA; Rodan, SB; Stump, GL; Wallace, AA | 1 |
5 review(s) available for arginyl-glycyl-aspartic acid and Osteoporosis
| Article | Year |
|---|---|
[Osteopontin].
Topics: Amino Acid Motifs; Animals; Bone Resorption; Gene Deletion; Humans; Hyaluronan Receptors; Oligopeptides; Osteoblasts; Osteoclasts; Osteogenesis; Osteopontin; Osteoporosis; Sialoglycoproteins | 2004 |
Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis.
Topics: Amino Acid Sequence; Animals; Bone Resorption; Cell Adhesion; Humans; Integrins; Ligands; Molecular Sequence Data; Oligopeptides; Osteoclasts; Osteoporosis | 1994 |
Structure and molecular regulation of bone matrix proteins.
Topics: Bone Matrix; Collagen; Extracellular Matrix Proteins; Gene Expression Regulation; Glycoproteins; Humans; Oligopeptides; Osteoporosis; Phosphorylation; Protein Biosynthesis; Proteoglycans; Stereoisomerism | 1993 |
Echistatin, a potential new drug for osteoporosis.
Topics: Animals; Bone Resorption; Humans; Integrins; Intercellular Signaling Peptides and Proteins; Oligopeptides; Osteoporosis; Peptides; Platelet Aggregation Inhibitors; Viper Venoms | 1993 |
Approach to discovering novel therapeutic agents for osteoporosis based on integrin receptor blockade.
Topics: Amino Acid Sequence; Bone Resorption; Chemistry, Pharmaceutical; Female; Humans; Integrins; Molecular Sequence Data; Oligopeptides; Osteoporosis; Peptides | 1995 |
11 other study(ies) available for arginyl-glycyl-aspartic acid and Osteoporosis
| Article | Year |
|---|---|
Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.
Topics: Amides; Binding, Competitive; Drug Design; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Molecular Conformation; Molecular Mimicry; Oligopeptides; Osteoporosis; Platelet Aggregation; Receptors, Vitronectin; Structure-Activity Relationship | 2002 |
Inhibition of osteoporosis by the αvβ3 integrin antagonist of rhodostomin variants.
Topics: Animals; Disintegrins; Female; Humans; Integrin alphaVbeta3; Male; Mice; Mutation; Oligopeptides; Osteoporosis; Peptides; Protein Domains; Rats; Serum Albumin | 2017 |
Synthesis, evaluation and 3D QSAR analysis of novel estradiol-RGD octapeptide conjugates with oral anti-osteoporosis activity.
Topics: Administration, Oral; Alkaline Phosphatase; Animals; Blood Coagulation; Calcium; Endometrial Hyperplasia; Estradiol; Female; Femur; Mice; Mice, Inbred ICR; Minerals; Models, Molecular; Molecular Conformation; Oligopeptides; Organ Size; Osteoporosis; Phosphorus; Quantitative Structure-Activity Relationship; Reference Standards; Thromboembolism; Uterus | 2009 |
3D QSAR of novel estrogen-RGD peptide conjugates: getting insight into structural dependence of anti-osteoporosis activity and side effect of estrogen in ERT.
Topics: Amino Acid Sequence; Animals; Bone and Bones; Computer Simulation; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mice; Models, Chemical; Oligopeptides; Osteoporosis; Peptides; Quantitative Structure-Activity Relationship | 2009 |
Homocysteine induces serum amyloid A3 in osteoblasts via unlocking RGD-motifs in collagen.
Topics: 3T3 Cells; Animals; Base Sequence; beta Catenin; Cell Line; Chemokine CCL5; Collagen Type I; Extracellular Matrix; fas Receptor; Focal Adhesion Kinase 1; Gene Expression; Homocysteine; Humans; Hyperhomocysteinemia; Matrix Metalloproteinase 13; Mice; Models, Biological; Oligopeptides; Osteoblasts; Osteoporosis; Paxillin; Protein Denaturation; RNA, Messenger; RNA, Small Interfering; Serum Amyloid A Protein; Signal Transduction | 2013 |
[Distribution of tetracycline-arginine-glycine-aspartate-tyrosine in mice and its effect on bone].
Topics: Animals; Bone Density; Bone Remodeling; Female; Mice; Oligopeptides; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Tetracycline; Tissue Distribution; Tyrosine | 2004 |
Bone loss induced by ovariectomy in rats is prevented by gene transfer of parathyroid hormone or an Arg-Gly-Asp-containing peptide.
Topics: Animals; Bone Density; Female; Oligopeptides; Organ Size; Osteoporosis; Ovariectomy; Parathyroid Hormone; Rats; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Uterus | 2005 |
Nonpeptide alpha(v)beta3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimetics.
Topics: Animals; Dogs; Heterocyclic Compounds, 2-Ring; Integrin alphaVbeta3; Models, Chemical; Molecular Structure; Oligopeptides; Osteoporosis; Structure-Activity Relationship | 2005 |
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
Topics: Alkaline Phosphatase; Animals; Calcium; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Hyperplasia; Mice; Oligopeptides; Organ Size; Osteoporosis; Ovariectomy | 2007 |
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.
Topics: Amino Acids; Animals; Bone and Bones; Bone Resorption; Calcitonin; Calcium; Cell Adhesion; Cells, Cultured; Dentin; Female; Humans; Integrins; Oligopeptides; Osteoclasts; Osteoporosis; Ovariectomy; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Receptors, Vitronectin; Vitronectin | 1997 |
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacements.
Topics: Amino Acids; Animals; Aspartic Acid; Binding, Competitive; Dogs; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Molecular Mimicry; Oligopeptides; Osteoporosis; Protein Binding; Receptors, Vitronectin; Structure-Activity Relationship | 2002 |